The following is an excerpt from Becker’s Healthcare Hospital Review. Immunology experts have not concluded that more COVID-19 boosters are necessary despite Pfizer and Moderna’s efforts to promote the shots, Kaiser Health News reported March 21. On March 13, Pfizer CEO Albert […]
Experts: skeptical of more Covid-19 boosters despite drugmakers’ efforts Read More »
The following is an excerpt from Becker’s Healthcare – Hospital CFO Report. “Right now, we don’t have enough money for fourth doses, if they’re called for,” Jeff Zients, White House Covid-19 response coordinator, said on a forthcoming episode of the
(READ) White House says it has no money to buy 4th doses of Covid-19 vaccine Read More »
The biggest new hope for a blockbuster drug to cure Alzheimer’s has been mired in controversy ever since it went to market. Critics say it’s a sign of declining standards and conflicts of interest at the FDA. And now, the
FDA Adviser Dr. Caleb Alexander of John’s Hopkins talks about Aducanumab/Aduhelm: a groundbreaking Alzheimer’s treatment sent to market in one of the most controversial FDA approvals ever.
An Alzheimer’s drug brought to market in one of the most controversial FDA approval processes ever– is the subject of my cover story this week on Full Measure. Aducanumab, now sold as Aduhelm, was introduced last June at a cost
In light of the recent close call with airlines, what are the health and safety concerns with 5G technology?
Full Measure After Hours: 5G Whiz and Safety Concerns (PODCAST) Read More »
The watchdog group Judicial Watch has filed a Freedom of Information Act (FOIA) lawsuit against the Department of Health and Human Services (HHS). It’s asking for records of communications from Dr. Marion Gruber and Dr. Philip Krause. They are two high ranking scientists
Rep. James Comer (R-Kentucky), the lead Republican on the House Oversight Committee, has sent a letter to Food & Drug Administration (FDA) Acting Commissioner Janet Woodcock expressing concerns over more reports that the Biden Administration is improperly interfering at the
(READ) Rep. Comer asks FDA about ‘improper interference’ in Covid booster approval Read More »
